Idiopatic Systemic Capillary Leak Syndrome Treated Successfully with High-Dose Intravenous Immunoglobulins
BANTAO Journal · 2015
DOI: 10.1515/bj-2015-0019 ↗Kurz gefasst
Fachartikel in der Zeitschrift BANTAO Journal, 2015. Verfasst von Ferhat Ekinci und 6 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).
Abstract (Originalsprache)
Idiopathic systemic capillary leak syndrome (ISCLS) is characterized by a triad of hypotension, hemoconcentration and hypoalbuminemia due to a shift of intravascular fluid and albumin to the extravascular area. We describe a hypovolemic patient with hemoconcentration and hypoalbuminemia who was successfully treated with high-dose intravenous immunoglobulins (IVIG). The purpose of this case report is to discuss the clinical management of idiopathic systemic capillary leak syndrome on the background of relevant literature review.
Zitieren
APA
Ekinci, F., Soyaltın, U. E., Akar, H., Ugur, M. C., Ersoy, E., Komac, A., & Yildirım, T. D. (2015). Idiopatic Systemic Capillary Leak Syndrome Treated Successfully with High-Dose Intravenous Immunoglobulins. BANTAO Journal. https://doi.org/10.1515/bj-2015-0019
Vancouver
Ekinci F, Soyaltın UE, Akar H, Ugur MC, Ersoy E, Komac A, et al. Idiopatic Systemic Capillary Leak Syndrome Treated Successfully with High-Dose Intravenous Immunoglobulins. BANTAO Journal. 2015. doi:10.1515/bj-2015-0019
BibTeX
@article{Ekinci2015,
author = {Ekinci, Ferhat and Soyaltın, Utku Erdem and Akar, Harun and Ugur, Mehmet Can and Ersoy, Ercan and Komac, Andac and Yildirım, Tuba Demirci},
title = {Idiopatic Systemic Capillary Leak Syndrome Treated Successfully with High-Dose Intravenous Immunoglobulins},
journal = {BANTAO Journal},
year = {2015},
doi = {10.1515/bj-2015-0019}
}
EUVIMED